Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

Myeloid-derived suppressor cells (MDSCs) are capable of suppressing the immune response. 5-Fluorouracil (5-FU) compared to other chemotherapy drugs have shown considerable decreases in the number of MDSCs without visible effects on T, B and natural killer cells, as well as dendritic cells (DCs). DC-...

Full description

Bibliographic Details
Main Authors: Najmeh khosravianfar, Jamshid Hadjati, Afshin Namdar, Roobina Boghozian, Morteza Hafezi, Mahboubeh Ashourpour, Nasim Kheshtchin, Mahsa Banitalebi, Reza Mirzaei, Seyed Alireza Razavi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2018-02-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1331
_version_ 1811277666025734144
author Najmeh khosravianfar
Jamshid Hadjati
Afshin Namdar
Roobina Boghozian
Morteza Hafezi
Mahboubeh Ashourpour
Nasim Kheshtchin
Mahsa Banitalebi
Reza Mirzaei
Seyed Alireza Razavi
author_facet Najmeh khosravianfar
Jamshid Hadjati
Afshin Namdar
Roobina Boghozian
Morteza Hafezi
Mahboubeh Ashourpour
Nasim Kheshtchin
Mahsa Banitalebi
Reza Mirzaei
Seyed Alireza Razavi
author_sort Najmeh khosravianfar
collection DOAJ
description Myeloid-derived suppressor cells (MDSCs) are capable of suppressing the immune response. 5-Fluorouracil (5-FU) compared to other chemotherapy drugs have shown considerable decreases in the number of MDSCs without visible effects on T, B and natural killer cells, as well as dendritic cells (DCs). DC-based vaccines considered to be appropriate candidates for cancer immunotherapy. However, due to the presence of various factors like MDSCs in tumor microenvironment, DC vaccine cannot effectively perform its function. The purpose of this study was to evaluate the effect of low doses of 5-FU on the efficacy of DC-based vaccines in preventing and treating of melanoma tumor model. This research was performed on 28 melanoma tumor bearing C57BL/6 female mice. The mice were randomly divided to 4 groups, group 1 is control population while group 2 and 3 were treated with DC vaccine and 5-FU respectively and group 4 was treated with both DC Vaccine and 5-FU. The mice survival, tumor growth rate, number of MDSC and CD8+/ CD107a+ T cells in mice spleen were evaluated in each group with maximum result in group 4. Our results revealed that combination of DC vaccine and 5-FU reduced number of MDSCs (3%) and also tumor growth rate(10%)(p<0.05) and increased mice survival (70%) and increased CD8+ /CD107a+ T cells (25%). This study have shown that combinational therapy with DC vaccine improved immunity in tumor mice compared to the therapy consisting of DC vaccine or 5-FU only.
first_indexed 2024-04-13T00:20:52Z
format Article
id doaj.art-09ac869cebf6409d8efd0bc7ad304a3e
institution Directory Open Access Journal
issn 1735-1502
1735-5249
language English
last_indexed 2024-04-13T00:20:52Z
publishDate 2018-02-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Allergy, Asthma and Immunology
spelling doaj.art-09ac869cebf6409d8efd0bc7ad304a3e2022-12-22T03:10:46ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492018-02-011711331Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor MiceNajmeh khosravianfar0Jamshid Hadjati1Afshin Namdar2Roobina Boghozian3Morteza Hafezi4Mahboubeh Ashourpour5Nasim Kheshtchin6Mahsa Banitalebi7Reza Mirzaei8Seyed Alireza Razavi9Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, IranDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, IranMyeloid-derived suppressor cells (MDSCs) are capable of suppressing the immune response. 5-Fluorouracil (5-FU) compared to other chemotherapy drugs have shown considerable decreases in the number of MDSCs without visible effects on T, B and natural killer cells, as well as dendritic cells (DCs). DC-based vaccines considered to be appropriate candidates for cancer immunotherapy. However, due to the presence of various factors like MDSCs in tumor microenvironment, DC vaccine cannot effectively perform its function. The purpose of this study was to evaluate the effect of low doses of 5-FU on the efficacy of DC-based vaccines in preventing and treating of melanoma tumor model. This research was performed on 28 melanoma tumor bearing C57BL/6 female mice. The mice were randomly divided to 4 groups, group 1 is control population while group 2 and 3 were treated with DC vaccine and 5-FU respectively and group 4 was treated with both DC Vaccine and 5-FU. The mice survival, tumor growth rate, number of MDSC and CD8+/ CD107a+ T cells in mice spleen were evaluated in each group with maximum result in group 4. Our results revealed that combination of DC vaccine and 5-FU reduced number of MDSCs (3%) and also tumor growth rate(10%)(p<0.05) and increased mice survival (70%) and increased CD8+ /CD107a+ T cells (25%). This study have shown that combinational therapy with DC vaccine improved immunity in tumor mice compared to the therapy consisting of DC vaccine or 5-FU only.https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1331Dendritic cell5- FluorouracilMyeloid-derived suppressor cellTumor
spellingShingle Najmeh khosravianfar
Jamshid Hadjati
Afshin Namdar
Roobina Boghozian
Morteza Hafezi
Mahboubeh Ashourpour
Nasim Kheshtchin
Mahsa Banitalebi
Reza Mirzaei
Seyed Alireza Razavi
Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice
Iranian Journal of Allergy, Asthma and Immunology
Dendritic cell
5- Fluorouracil
Myeloid-derived suppressor cell
Tumor
title Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice
title_full Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice
title_fullStr Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice
title_full_unstemmed Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice
title_short Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice
title_sort myeloid derived suppressor cells elimination by 5 fluorouracil increased dendritic cell based vaccine function and improved immunity in tumor mice
topic Dendritic cell
5- Fluorouracil
Myeloid-derived suppressor cell
Tumor
url https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1331
work_keys_str_mv AT najmehkhosravianfar myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT jamshidhadjati myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT afshinnamdar myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT roobinaboghozian myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT mortezahafezi myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT mahboubehashourpour myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT nasimkheshtchin myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT mahsabanitalebi myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT rezamirzaei myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice
AT seyedalirezarazavi myeloidderivedsuppressorcellseliminationby5fluorouracilincreaseddendriticcellbasedvaccinefunctionandimprovedimmunityintumormice